{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:47:15Z","timestamp":1778672835502,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.amepre.2021.01.025","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T21:27:05Z","timestamp":1616794025000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018"],"prefix":"10.1016","volume":"61","author":[{"given":"Leanne","family":"Teoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin C.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Gellad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amepre.2021.01.025_bib0001","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/15563650.2018.1457792","article-title":"Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014","volume":"56","author":"Calcaterra","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.amepre.2021.01.025_bib0002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.18773\/austprescr.2014.033","article-title":"Pharmaceutical drug misuse in Australia","volume":"37","author":"Dobbin","year":"2014","journal-title":"Aust Prescr"},{"issue":"7","key":"10.1016\/j.amepre.2021.01.025_bib0003","first-page":"2121","article-title":"Addiction: part I. Benzodiazepines\u2013side effects, abuse risk and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.amepre.2021.01.025_bib0004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3928\/0048-5713-19950301-06","article-title":"Epidemiology of benzodiazepine use and dependence","volume":"25","author":"Gold","year":"1995","journal-title":"Psychiatr Ann"},{"issue":"7","key":"10.1016\/j.amepre.2021.01.025_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/15563650.2019.1674321","article-title":"Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data","volume":"58","author":"Friedrich","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"10.1016\/j.amepre.2021.01.025_bib0006","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2021.01.025_bib0007","series-title":"Benzodiazepine drug class: drug safety communication\u2014boxed warning updated to improve safe use","year":"2020"},{"key":"10.1016\/j.amepre.2021.01.025_bib0008","series-title":"Therapeutic Guidelines: Oral and Dental Version 3","year":"2019"},{"key":"10.1016\/j.amepre.2021.01.025_bib0009","series-title":"Conscious sedation in dentistry: dental clinical guidance","year":"2017"},{"key":"10.1016\/j.amepre.2021.01.025_bib0010","unstructured":"Dental Practitioner's Formulary, British National Formulary. https:\/\/www.nice.org.uk\/bnf-uk-only. Accessed March 24, 2021."},{"key":"10.1016\/j.amepre.2021.01.025_bib0011","series-title":"Drug prescribing for dentistry: dental clinical guidance","year":"2016"},{"key":"10.1016\/j.amepre.2021.01.025_bib0012","series-title":"Access and Barriers to Care\u2014a Report From the Adult Dental Health Survey","year":"2009"},{"key":"10.1016\/j.amepre.2021.01.025_bib0013","series-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Equator Network, Enhancing the Quality and Transparency of Health Research","author":"von Elm","year":"2019"},{"key":"10.1016\/j.amepre.2021.01.025_bib0014","unstructured":"Population. U.S. Census Bureau. https:\/\/www.census.gov\/topics\/population.html. Accessed August 1, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0015","series-title":"Prescription cost analysis \u2013 England, 2017 [PAS]: National statistics. NHS Digital","year":"2019"},{"key":"10.1016\/j.amepre.2021.01.025_bib0016","unstructured":"Population Estimates. Office of National Statistics.https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates. Accessed August 1, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0017","unstructured":"PBS and RPBS Section 85 Date of Supply Data. Australian Government Department of Health. http:\/\/www.pbs.gov.au\/info\/statistics\/dos-and-dop\/dos-and-dop. Accessed August 1, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0018","unstructured":"The Pharmaceutical Benefits Scheme, browse by dental items. Australian Government Department of Health. http:\/\/www.pbs.gov.au\/browse\/dental. Updated March 1, 2021. Accessed August 1, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0019","unstructured":"Australian Statistics on Medicines. Australian Government Department of Health.http:\/\/www.pbs.gov.au\/info\/statistics\/asm\/asm-2011#info_on_asm. Accessed August 1, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0020","unstructured":"Australian Bureau of Statistics. Australian Government. http:\/\/www.abs.gov.au\/. Accessed August 30, 2020."},{"key":"10.1016\/j.amepre.2021.01.025_bib0021","series-title":"Open Government Licence for Public Sector Information","year":"2019"},{"issue":"3\u20134","key":"10.1016\/j.amepre.2021.01.025_bib0022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1071\/NB08067","article-title":"Comparison of the dental health of adults and children living in NSW with their counterparts in the U.S. and UK","volume":"20","author":"Blinkhorn","year":"2009","journal-title":"N S W Public Health Bull"},{"issue":"1","key":"10.1016\/j.amepre.2021.01.025_bib0023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12903-018-0630-3","article-title":"Socioeconomic status, oral health and dental disease in Australia, Canada, New Zealand and the United States","volume":"18","author":"Mejia","year":"2018","journal-title":"BMC Oral Health"},{"issue":"8","key":"10.1016\/j.amepre.2021.01.025_bib0024","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bdj.4812252","article-title":"Impacts of oral disorders in the United Kingdom and Australia","volume":"198","author":"Slade","year":"2005","journal-title":"Br Dent J"},{"issue":"5","key":"10.1016\/j.amepre.2021.01.025_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4303","article-title":"Comparison of opioid prescribing by dentists in the United States and England","volume":"2","author":"Suda","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.amepre.2021.01.025_bib0026","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1038\/s41598-020-65390-6","article-title":"Dental opioid prescribing rates after the up-scheduling of codeine in Australia","volume":"10","author":"Teoh","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.amepre.2021.01.025_bib0027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J Addict Med"},{"issue":"3","key":"10.1016\/j.amepre.2021.01.025_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0149-7634(05)80011-9","article-title":"Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review","volume":"17","author":"Rush","year":"1993","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.amepre.2021.01.025_bib0029","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0011-8532(02)00034-4","article-title":"Conscious sedation for dentistry: risk management and patient selection","volume":"46","author":"Jackson","year":"2002","journal-title":"Dent Clin North Am"},{"issue":"2","key":"10.1016\/j.amepre.2021.01.025_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2344\/anpr-66-01-08","article-title":"Illinois dental anesthesia and sedation survey for 2016","volume":"66","author":"Flick","year":"2019","journal-title":"Anesth Prog"},{"issue":"6","key":"10.1016\/j.amepre.2021.01.025_bib0031","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41415-019-0714-8","article-title":"A comparison of the sedation provision of NHS dental services 2014\u20122016 for local authorities throughout England","volume":"227","author":"Maguire","year":"2019","journal-title":"Br Dent J"},{"key":"10.1016\/j.amepre.2021.01.025_bib0032","series-title":"Australian Health Practitioner Regulation Agency, Dental Board of Australia","year":"2019"},{"key":"10.1016\/j.amepre.2021.01.025_bib0033","series-title":"Registrant data. Australian Health Practitioner Regulation Agency","year":"2020"},{"issue":"3","key":"10.1016\/j.amepre.2021.01.025_bib0034","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/AJP.0b013e31820215f5","article-title":"Temporomandibular disorders and associated clinical comorbidities","volume":"27","author":"Hoffmann","year":"2011","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.amepre.2021.01.025_bib0035","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00784-018-2454-6","article-title":"Treatment modalities for burning mouth syndrome: a systematic review [published correction appears in Clin Oral Investig. 2019;23(9):3657]","volume":"22","author":"de Souza","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.amepre.2021.01.025_bib0036","series-title":"The American Academy of Oral Medicine","year":"2015"},{"key":"10.1016\/j.amepre.2021.01.025_bib0037","series-title":"How Should Dentists Prescribe, Store, Order and Dispose of Controlled Drugs?","year":"2016"},{"key":"10.1016\/j.amepre.2021.01.025_bib0038","unstructured":"The poisons standard (the SUSMP). Australian Government, Department of Health, Therapeutic Goods Administration.https:\/\/www.tga.gov.au\/publication\/poisons-standard-susmp. Accessed December 13 2020."},{"issue":"1","key":"10.1016\/j.amepre.2021.01.025_bib0039","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12903-019-0882-6","article-title":"A survey of prescribing practices by general dentists in Australia","volume":"19","author":"Teoh","year":"2019","journal-title":"BMC Oral Health"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379721001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:58:38Z","timestamp":1760083118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379721001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0749379721001252"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2021.01.025","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2021.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}